Home
Resources
Publications
Pharmacophore Modeling, Homology Modeling, and in Silico Screening Reveal Mammalian Target of Rapamycin Inhibitory Activities for Sotalol, Glyburide, Metipranolol, Sulfamethizole, Glipizide, and Pioglitazone

Pharmacophore Modeling, Homology Modeling, and in Silico Screening Reveal Mammalian Target of Rapamycin Inhibitory Activities for Sotalol, Glyburide, Metipranolol, Sulfamethizole, Glipizide, and Pioglitazone

Mohammad A Khanfar, Majed M AbuKhader, Saja Alqtaishat, Mutasem O Taha

J Mol Graph Model. 2013 May;42:39-49.

PMID: 23545333

Abstract:

Mammalian target of rapamycin (mTOR) is a serine/threonine kinase and member of the PI3K-related kinase (PIKK) family. It plays a central role in integrating signals from metabolism, energy homeostasis, cell cycle, and stress response. Aberrant PI3K/mTOR activation is commonly observed in diseases such as cancer, diabetes and Alzheimer's disease. Accordingly, we developed common feature binding hypotheses for a set of 6 potent mTOR antagonists. The generated models were validated using receiver operating characteristic (ROC) curve analyses. To gain better insight into ligand-mTOR interactions, a homology model for the kinase domain of mTOR was built using the crystallographic structure of PI3Kγ as template. The optimal pharmacophore model was further improved based on detailed docking studies of potent training compound in the homology model. The modified binding model was employed as 3D search query to screen our in-house-built database of established drugs. Subsequent in vitro screening of captured hits showed that six of them have submicromolar to low micromolar bioactivities, namely, glyburide, metipranolol, sulfamethizole, glipizide, pioglitazone, and sotalol.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP16673340	Glyburide Related Compound A		16673-34-0	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: